Search

Search Results
Results 221 - 229 of 229 for Acute pain
  • Dutasteride/tamsulosin Viatris 500/400
    Drug - 23 Jan 2026
    Consumer Medicine Information (CMI) about Dutasteride/tamsulosin Viatris 500/400 intended for persons living in Australia.
  • Sudafed Sinus and Nasal Decongestant Tablets
    Drug - 22 Jan 2026
    Consumer Medicine Information (CMI) about Sudafed Sinus and Nasal Decongestant Tablets intended for persons living in Australia.
  • Zypine and Zypine ODT
    Drug - 6 Jan 2026
    Consumer Medicine Information (CMI) about Zypine and Zypine ODT intended for persons living in Australia.
  • Xolair
    Drug - 29 Oct 2025
    Consumer Medicine Information (CMI) about Xolair intended for persons living in Australia.
  • Fasenra Pen
    Drug - 2 Jul 2025
    Consumer Medicine Information (CMI) about Fasenra Pen intended for persons living in Australia.
  • Coveram
    Drug - 2 May 2024
    Consumer Medicine Information (CMI) about Coveram intended for persons living in Australia.
  • Ventolin Injection
    Drug - 13 Feb 2024
    Consumer Medicine Information (CMI) about Ventolin Injection intended for persons living in Australia.
  • Clozaril
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Clozaril intended for persons living in Australia.
  • DBL Potassium Dihydrogen Phosphate Concentrated
    Drug - 30 Jan 2023
    Consumer Medicine Information (CMI) about DBL Potassium Dihydrogen Phosphate Concentrated intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback